GGrantIndex
Sort

130,381 grants matching hiv

Integrated Care Clinics for IDUs in India: a cluster randomized trial

$1,279,936
Gregory M Lucas · Johns Hopkins University · R01 · FY2012 · DA

Couples HIV Counseling &Testing in two African capitals

$1,279,877
Emory University · R01 · FY2005 · MH

Johns Hopkins University Kampala-Nanning Clinical Trial Unit

$1,279,706
Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2015 · AI

Expanded SPF Rhesus Macaque Breeding Colony for AIDS Research

$1,279,656
Michael K Axthelm · Oregon Health & Science University · U42 · FY2016 · OD

Phase I therapeutic testing of viral-vectored vaccines that shift CD8+ T cell immunodominance to conserved regions of HIV-1

$1,279,617
Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U01 · FY2020 · AI

SPORE in Cervical Cancer

$1,279,343
T.-C. Wu · Johns Hopkins University · P50 · FY2019 · CA

HIV persistence in vivo

$1,279,134
Eli Boritz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Molecular Mechanisms of HIV Latency

$1,278,759
Eric M Verdin · Buck Institute For Research On Aging · R01 · FY2017 · DA

Development of Dendrimer and Combination Microbicides

$1,278,753
Starpharma, Ltd · U19 · FY2005 · AI

Duke University Center for Translational Research

$1,278,660
Duke University · P30 · FY2002 · AI

Harnessing Data Science to Promote Equity in Injury and Surgery for Africa

$1,278,560
Alain Mefire Chichom · University Of Buea · U54 · FY2023 · TW

Search for the Structural Basis of Biomacromolecular Function and Activity

$1,278,532
Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Molecular Epidemiology Studies of Occupational and Environmental Exposures

$1,278,262
Nathaniel Rothman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA

Multitargeted Microbicide Combinations to Block HIV

$1,278,205
Mount Sinai School Of Medicine Of Nyu · U19 · FY2004 · HD

Childhood ‘Omics’ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings

$1,278,151
Adithya Cattamanchi · University Of California-Irvine · R01 · FY2024 · AI

Targeting ensembles of Drug Resistant HIV Proteases

$1,278,108
Celia A. Schiffer · Univ Of Massachusetts Med Sch Worcester · P01 · FY2006 · GM

Core B: Developmental

$1,277,989
Ann Cornwall Collier · University Of Washington · P30 · FY2022 · AI

REDUCE POSTNATAL TRANSMISSION OF HIV THROUGH BREASTMILK

$1,277,983
Boston University Medical Campus · R01 · FY2002 · HD

Crosstalk Among Oral & Gastrointestinal Soluble Innate Factors, HIV, & Microbes

$1,277,521
Daniel Malamud · New York University · U19 · FY2007 · DE

ADOLESCENT TRIAL NETWORK FOR HIV/AIDS BALTIMORE

$1,277,359
University Of Maryland Baltimore · U01 · FY2005 · HD

Vaccine immunogenicity and efficacy in the rhesus macaque/SHIV model

$1,277,195
Ruth Margrit Ruprecht · University Of Louisiana At Lafayette · U19 · FY2023 · AI

Genetic Aspects Of Viral Oncogenesis In Inbred Strains and Wild Mouse Species

$1,277,173
Christine Kozak · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Studies of Rare Cancers

$1,277,160
Katherine McGlynn · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA

Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection

$1,276,503
Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2023 · AI

CV-N Secreting Lactobacilli and Retrocyclin Microbicides

$1,276,143
Phalguni Gupta · University Of Pittsburgh At Pittsburgh · U19 · FY2007 · AI